In Table 6, the consumption of H03A (thyroid preparations) and H05A (parathyroid hormones) medicines is analyzed, comparing patients with thyroid cancer (ICD-10 C73) and patients with other cancers (ICD-10 not C73), who showed substantial differences. This evidence concerns the gene PTH and cancer.